AACR 2026 Special Report: An In-Depth Review of Medicilon’s Three Technical Posters | Bilingual

Preclinical CRO

The AACR Annual Meeting convenes leading cancer experts in San Diego, California, from April 17-22, 2026. Medicilon, with over 20 years of preclinical CRO experience, is represented by Dr. Qingcong Lin, Dr. Mingfeng Bai, and Dr. Steven Zhang. The team is presenting three technical posters highlighting Medicilon’s integrated solutions in conjugate drug analysis, autoimmune CAR-T evaluation models, and end-to-end AOC/RNAi drug […]

AACR 2026

Friday, April 17, 2026,
to Wednesday, April 25, 2026

Search Medicilon

Preclinical CRO

Medicilon Delivers One Stop Preclinical Support as Yizhong Pharma Secures NMPA Clinical Approval for YXC‑001 Tri‑functional Antibody Fusion Protein and YXC‑002 4th‑Generation EGFR Kinase Inhibitor

Preclinical CRO

4th SMC and AimedBio ADC Conference

Preclinical CRO

ACS Fall 2026

Contact Medicilon

Name(Required)
Address(Required)